Financial News

Financial Report: Bioanalytical Systems, Inc.

Preclinical services offsets decline in bioequivalence studies

Bioanalytical Systems, Inc.

4Q Revenues: $5.2 million (+4%)

4Q Loss: $2.0 million (loss of $721,000 4Q15)

FY Revenues:$20.4 million (-10%)

FY Loss: $3.2 million (earnings were $1.1 million FY15)

Comments: Service revenue for the year was negatively impacted by fewer bioequivalence studies as well as fewer samples received and analyzed, as well as an increase in method development and validation projects, which generate lower revenue but involve more dedicated resources.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters